BMK aids minimally invasive surgeries with advanced spinal devices
As the foreign company that has gained the most approvals in China for its spinal surgical instruments, BMK is keen on sharing its expertise
[Country Business Reports interviews and articles by Discovery Reports www.discoveryreports.com]
Navigating a patient’s anatomy in error-free or more stable ways has driven advancements in the medical device industry of late. The global medical community is championing procedures that are less invasive and offer reduced post-operational pain and recovery time. These minimally invasive operations require unconventional equipment and technology. Consequently, today’s cutting-edge medical tools undergo strict approval methods from international regulatory and certification bodies.
Seeking approvals is a painstaking process, but South Korea’s leading medical device manufacturer BM Korea (BMK) is undisturbed. As the only foreign company that has gained the most approvals in China for its spinal surgical instruments, BMK is keen on elevating patient care and supporting minimally invasive surgery by sharing its expertise in Asia and the rest of the world.
Developing its own technology, BMK has achieved groundbreaking strides in the areas of endoscopy, neurosurgery and orthopaedic surgery. Thanks to its latest breakthrough, the Endocare line, surgeons can now expand the view of a treatment area that is usually difficult to see when applying minimally invasive surgery.
The Endocare system features a camera lens with light specifications. With BMK’s state-of-the-art spinal endoscope, surgeons can diagnose fractures and spinal diseases more accurately. The technology has passed initial approvals in Asia, and will soon be ready for commercialisation in India, China and Europe.
“The know-how for Endocare system came from us,” says Patterson Ryu, president of BMK. “We make our own products without any help from other companies. We are known for our spinal technology, and we have been successful in getting the certifications for our devices.”
The next step for the company will be to get approvals from other areas, such as the Conformité Européene or CE Marking in Europe, the United States Food and Drug Administration and the China Food and Drug Administration, to make the systems available to a wider market.
